Adage Capital Partners’s Olema Oncology, Inc. Common Stock OLMA Stock Holding History

Adage Capital Partners’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-275,000	Closed	-$4.1M	–	1061
2026 Q1	$4.1M	Buy	275,000 +65,000	+31%	+$1.45M	0.01%	789
2025 Q4	$5.25M	Buy	+210,000	New	+$3.74M	0.01%	757
2025 Q1	–	Sell	-365,198	Closed	-$2.13M	–	914
2024 Q4	$2.13M	Sell	365,198 -34,802	-9%	-$348K	﹤0.01%	788
2024 Q3	$4.78M	Buy	400,000 +75,000	+23%	+$959K	0.01%	719
2024 Q2	$3.52M	Sell	325,000 -135,000	-29%	-$1.46M	0.01%	743
2024 Q1	$5.21M	Sell	460,000 -40,000	-8%	-$516K	0.01%	695
2023 Q4	$7.02M	Buy	500,000 +111,018	+29%	+$1.49M	0.01%	649
2023 Q3	$4.8M	Buy	388,982 +157,549	+68%	+$1.61M	0.01%	666
2023 Q2	$2.09M	Sell	231,433 -188,567	-45%	-$1.14M	﹤0.01%	739
2023 Q1	$1.46M	Hold	420,000	–	–	﹤0.01%	785
2022 Q4	$1.03M	Hold	420,000	–	–	﹤0.01%	840
2022 Q3	$1.16M	Sell	420,000 -80,000	-16%	-$339K	﹤0.01%	884
2022 Q2	$2.04M	Buy	500,000 +411,203	+463%	+$1.3M	﹤0.01%	878
2022 Q1	$378K	Buy	+88,797	New	+$489K	﹤0.01%	966
2021 Q3	–	Sell	-225,000	Closed	-$6.3M	–	1051
2021 Q2	$6.3M	Buy	+225,000	New	+$6.4M	0.01%	790

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners's OLMA Position: Q2 2026 in Review

Adage Capital Partners sold out of Olema Oncology, Inc. Common Stock (OLMA) in Q2 2026, closing a stake of 275,000 shares — an estimated $4.1M sold.

Adage Capital Partners first reported a position in OLMA in Q2 2021 and held it in 15 quarters. The position peaked at $7.02M in Q4 2023. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Adage Capital Partners reported no remaining Olema Oncology, Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
Adage Capital Partners sold 275,000 Olema Oncology, Inc. Common Stock shares in Q2 2026, an estimated $4.1M.
Adage Capital Partners first reported a position in Olema Oncology, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
Adage Capital Partners's Olema Oncology, Inc. Common Stock position peaked at $7.02M in Q4 2023.
185 funds tracked by Wall St. Rank held Olema Oncology, Inc. Common Stock as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.